Home | Welcome to Contract Pharma   
Last Updated Friday, May 24 2013
Print

Collaborations & Alliances

Related Searches:

Filter by:

October 29, 2012
Extends Huntington’s collaboration through 2015   Read More »
October 24, 2012
Aims to simplify the supply chain and vendor management   Read More »
October 23, 2012
Abbott to use ADC technology for oncology targets   Read More »
October 23, 2012
Will co-develop and co-commercialize linaclotide   Read More »
October 22, 2012
EMA approves commercial production for Actavis drug   Read More »
October 22, 2012
Picks up portfolio, new ADHD treatment   Read More »
October 22, 2012
Offers $36 mil. for Dutch service provider   Read More »
October 18, 2012
Will begin Phase I trials of CUDC-907   Read More »
October 17, 2012
Three-year pact covers safety assessment, development DMPK   Read More »
October 16, 2012
$5 mil. upfront for exclusive license for candidates   Read More »
October 15, 2012
Services team will work out of Beijing lab   Read More »
October 15, 2012
Finnish pact begins with Phase I   Read More »
October 12, 2012
Paladin Licenses MOXDU for Canadian Sales   Read More »
October 11, 2012
To provide formulation development for Astimex product   Read More »
October 9, 2012
To develop treatments for hematological malignancies and solid tumors   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On